KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25

- Run an exhibit booth at the bio exhibition which will be held in Taipei, Taiwan for four days starting from July 25

- Exploring partnership with local and global companies considering entry into the US and Japanese markets

TAIPEI, July 22, 2024 /PRNewswire/ -- KOLON Biotech(CEO Sun-jin Kim), a subsidiary of KOLON Life Science Inc., announced on July 22 that it is running its own exhibit booth at BIO Asia-Taiwan 2024, which will be held in Taipei, Taiwan for four days from July 25.

BIO Asia-Taiwan 2024 is the largest bio exhibition in the country, co-organized by Biotechnology Innovation Organization (BIO) of the United States and Taiwan BIO. This year, it provides about 800 participating companies to regionally and globally link the production and value chains within the industry.

KOLON Biotech plans to strengthen its global networking by opening a solo booth at Hall 1 of Taipei Nangang Exhibition Center and exploring various business collaborations with global biotech companies including Taiwanese companies. In particular, it aims to secure mid to long-term partnerships with Taiwanese biotech companies which are developing excellent pipelines targeting the US and Japanese markets. It is expected that KOLON Biotech's cooperation model of providing samples at affordable cost and utilizing its excellent Chemistry, Manufacturing and Controls (CMC^[1]).

KOLON Biotech will make an introduction to its Contract Development and Manufacturing Organization (CDMO^[2]) service. This model allows the companies preparing for early-stage clinical trials to provide scalable process setup services leveraging accumulated commercialization experience. For those preparing for late-stage clinical trials, KOLON Biotech can deliver high-quality and high-yield products at reasonable price by applying its 2D Automated Closed Platform technology.

"Taiwan is one of the leading biomedical industry hubs in Asia and we plan to introduce our excellent process development services and capabilities to Asian companies considering the entry into the US or Japanese markets," said Sun-jin Kim, CEO at KOLON Biotech.

KOLON Biotech has been operating CDMO and Contract Manufacturing Organization (CMO^[3]) specialized in advanced biopharmaceuticals, such as cell therapy, gene therapy and exosome therapy, based on its more than 20 years of experience. It has produced more than 100 commercial batches successfully in Korea alone and is gearing up itself for a number of projects for the commercial supply to Japan and the US.

^[1] Chemistry, Manufacturing, and Controls

^[2] Contract Development and Manufacturing Organization

^[3] Contract Manufacturing Organization

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25

Combining AI algorithms, big data, and cloud connectivity to significantly improve appliance energy efficiency, without sacrificing performance

BERLIN, Sept. 7, 2024 /PRNewswire/ -- Midea, the world's leading manufacturer in air treatment and home appliances, unveiled its ECOMASTER energy-saving solution at Booth 101, Hall 5.1, during IFA Berlin 2024, the world's largest consumer and electronics show. This intelligent technology optimizes product performance and reduces energy consumption by an average of 30%.

"Our users have made it clear that they care about reducing energy use and protecting the environment, and we aim to deliver," said Kurt Jovais, Global Director of Product Management, Midea International Business. "Combining cloud connectivity, advanced analytics, and an intelligent AI algorithm, ECOMASTER achieves the perfect balance between performance and energy efficiency."

As an example, an ECOMASTER air conditioner leverages an AI algorithm pre-trained on billions of data points, continuously detecting environmental data every 30 seconds, integrating cloud-based data such weather forecasts to predict heat load changes. This enhances its predictive abilities, ensuring precise temperature control and optimizing comfort and energy efficiency for the optimal cooling experience.

Midea ECOMASTER is compatible across various Midea appliances including refrigerators, washing machines, ovens, dishwashers and water heaters. When activated, the ECOMASTER autonomously optimizes energy use, and users can monitor energy savings through the app.

The power of ECOMASTER is further amplified when paired with the ESS Energy Management System. The tailored AI Energy Assistant adjusts to users' preferences for storing, charging, and discharging energy based on dynamic electricity tariffs, and employs strategies for intelligent energy allocation.

Midea also respects user privacy. All uploaded data is operational, such as indoor and compressor temperatures, containing no personal information and only remaining available to the user.

Midea ECOMASTER represents Midea's latest achievement in utilizing advanced technology to develop energy-saving and user-friendly appliances for the home.

About Midea & Midea Group

Midea is one of over 10 brands within the Smart Home Business of Midea Group.

Established in 1968, Midea Group is a leading global high-technology company, ranked #277 on the 2024 Fortune Global 500 list. It is one of the world's largest home appliance manufacturers. In early 2021, the company streamlined its core units into five high-growth business pillars: Smart Home, Electro-Mechanical, Building Technologies, Robotics & Automation, and Digital Innovation.

www.midea-group.com
www.midea.com 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Midea's New ECOMASTER Energy-Saving Solution Shines at IFA Berlin 2024